2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach

$1,496,000U54FY2025CANIH

Sloan-Kettering Inst Can Research, New York NY

Investigators

Francesca M Ganycontact Adriana Espinosa Bao Q Vuong

Linked publications & trials

Paper 39578657 Paper 39513941 Paper 39480554 Paper 39467204 Paper 39450264 Paper 39430038 Paper 39169605 Paper 38767862 Paper 38736736 Paper 38687180 Paper 38617252 Paper 38520472 Paper 38414130 Paper 38383552 Paper 38343223 Paper 38152038 Paper 38010367 Paper 37961463 Paper 37934337 Paper 37924476 Paper 37890492 Paper 37769509 Paper 37714845 Paper 37555910 Paper 37413982 Paper 37370818 Paper 37370195 Paper 37365386 Paper 37322364 Paper 37296840 Paper 37259669 Paper 37232458 Paper 37214848 Paper 37096888 Paper 37032593 Paper 37020153 Paper 36797410 Paper 36717389 Paper 36635535 Paper 36603026 Paper 36530123 Paper 36514954 Paper 36444126 Paper 36399067 Paper 36369620 Paper 36356044 Paper 36282533 Paper 36279076 Paper 36271879 Paper 36245186 Paper 36219358 Paper 36192754 Paper 36190107 Paper 36179271 Paper 36130287 Paper 36032549 Paper 35953894 Paper 35902442 Paper 35709430 Paper 35672534 Paper 35503911 Paper 35503020 Paper 35315588 Paper 35301804 Paper 35253716 Paper 35118900 Paper 34817750 Paper 34758310 Paper 34721515 Paper 34577800 Paper 34381455 Paper 34366276 Paper 34357556 Paper 34351358 Paper 34329530 Paper 34291359 Paper 34169329 Paper 34161601 Paper 34140197 Paper 34117110 Paper 34043437 Paper 34012006 Paper 33985945 Paper 33970137 Paper 33831416 Paper 33410795 Paper 33340187 Paper 33106995 Paper 33098766 Paper 33025364 Paper 32916670 Paper 32914912 Paper 32844367 Paper 32832867 Paper 32583351 Paper 32439562 Paper 32432881 Paper 32395282 Paper 32348501 Paper 32330607

Abstract

The CCNY-MSKCC Partnership has successfully created a mutually beneficial, cross-institutional collaboration that has emphasized research across the translational T0-T4 continuum, the creation of an education pipeline for attracting students to careers in cancer research, and the establishment of community networks and resources for conducting community engaged outreach and research for the next five years. The Partnership focus will be Translational Cancer Research. Consistent with this emphasis, our research projects will focus on: 1) understanding the biological and social factors associated with immune checkpoint inhibitors and evaluating an intervention designed to reduce side effect severity and improve treatment attendance; 2) an examination of small molecule regulation of cancer-driving transcription factors using a interdisciplinary strategy of protein chemistry, chemical, and cellular approaches that could lead to targeted treatments relevant to cancers; 3) the impact of AI integrated, UN-style medical interpreting engineering solutions on cancer care; 4) identification of germline and other factors influencing the tumor genome of lung cancers.

View original record on NIH RePORTER →